– June 1, 2012
June 1, 2012
View Issues
Tanning Beds Revisited
The practice of tanning by artificial means, such as by sunlamps or sunbeds, continues to be popular, particularly in young people despite the acknowledged risk for increased skin cancer.Responses, Albeit Few, for Ipilimumab-Treated Melanoma Patients with Brain Metastases
Ipilimumab has recently been approved for the treatment of advanced melanoma. The current trial was undertaken to determine its safety and efficacy in patients with brain involvement.Recurrent Meningioma: Systemic Therapy
The patient is a 56-year-old woman with known meningioma first resected in 1999 followed by external beam irradiation. In 2005, she developed progressive right leg weakness and had a second operation and course of radiation.Free Light Chain Levels Offer Predictive Value for Both Myelofibrosis and Myelodysplasia
Host-related immunoproliferation may contribute to the pathogenesis of certain clonal myeloid disorders such as myelofibrosis and myelodysplasia.Treatment Decisions for Patients with Newly Diagnosed Multiple Myeloma
Two very recent publications address the management of newly diagnosed multiple myeloma. In the first, two bortezomib-containing three-drug regimens proved equally effective as a more complex four-drug regimen in achieving meaningful initial responses. The second demonstrated the value of maintenance lenalidomide for achieving longer progression-free survival.Clinical Briefs in Primary Care Supplement
Pharmacology Watch
Drug shortages; metformin and cancer prevention; migraine prevention guidelines; and FDA actions.